Analysis of the Internal Environment of the Pharmaceutical Distributor Operation in Russia Using SWOT Analysis

Authors

  • O. Krylova Department of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russia
  • T. Litvinova Department of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russia
  • L. Babaskina Department of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russia
  • D. Babaskin Sechenov First Moscow State Medical University
  • O. Savinova Department of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russia

DOI:

https://doi.org/10.3889/oamjms.2020.3628

Keywords:

internal environment of the organization, pharmaceutical distributor with its own pharmacy warehouse, SWOT analysis, qualitative analysis, matrix of the SWOT analysis

Abstract

BACKGROUND: The general directions of the organization’s development should be clearly formulated, i.e., a business strategy should be developed in order to achieve the long-term competitive advantages in the operation of a pharmaceutical distributor with its own pharmacy warehouse in Russia.

AIM: Identification of strengths and weaknesses, opportunities and threats in the operation of a pharmaceutical distributor with its own pharmacy warehouse.

MATERIALS AND METHODS: The SWOT analysis was used to analyze the environment, which enabled a joint study of the external and internal environment. During the study, content analysis of secondary sources of information was used (data from the Federal State Statistics Service, DSM Group marketing agency), as well as sociological analysis.

RESULTS AND DISCUSSION: During the SWOT analysis, ten factors were identified that ensured the normal functioning of the pharmaceutical distributor, as well as 11 negative factors were identified that negatively affected the operation of the pharmacy warehouse. The article presents qualitative description of the strengths and weaknesses. Ten factors were attributed to the favorable opportunities for the organization’s activities; seven positions were considered as threats to the activities of the distributor. It should be noted that all factors of external environment are in a state of strong mutual influence. A change in one of the factors necessarily leads to a change in other factors. Therefore, their study and analysis should not be carried out separately, but systematically, with tracking not only the actual changes in one factor but also the process how these changes will affect other factors. After identifying strengths and weaknesses, opportunities and threats, a table was compiled and all intersections were analyzed, i.e., all possible pairwise combinations that would help determining the future strategy. At present, the strategic goal of a number of wholesale companies in the pharmaceutical market is defined as increasing return on investment.

CONCLUSION: In this article, SWOT analysis has been used to provide some suggestions on overcoming weaknesses and threats in the activities of a pharmaceutical distributor, as well as on proper use of strengths and opportunities. During the study, pharmaceutical industry practitioners discussed the impact of various economic factors, strengths, opportunities, weaknesses, and threats regarding the activities of pharmaceutical distributor, as well as related problems and prospects for the future.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Distribution of Drugs in Russia. Available from: https://www. ey.com/Publication/vwLUAssets/ey-blitz-survey-distribution-ofpharmaceuticals-in-russia/$FILE/ey-blitz-survey-distribution-ofpharmaceuticals-in-russia.pdf. [Last accessed on 2020 Aug 20].

Vesnin VR. Management. Moscow: Prospect; 2009.

Chevallier J, Ielpo F. The Economics of Commodity Markets. Chichester, West Sussex: John Wiley & Sons; 2013.

Clow KE, James KE. Essentials of Marketing Research: Putting Research into Practice. Thousand Oaks, Calif: SAGE Publications, Inc.; 2013.

Norm J. Adaptive Marketing: Leveraging Real-time Data to Become a More Competitive and Successful Company. New York: Palgrave Macmillan; 2015. https://doi. org/10.1057/9781137462930

Kerin R, Hartley S, Rudelius W. Marketing. 12th ed. New York: McGraw-Hill Education; 2014.

Pride WM, Ferrell OC. Marketing 2016. 18th ed. United States: Cengage Learning; 2016.

DSM Group. Itogi 2018 Goda. Results of 2018. Retail Segment of the Russian pharmaceutical market; 2019. Available from: https://www.dsm.ru/news/566. [Last accessed on 2020 Aug 20].

Demidova A. Pharmacy Chains Want to Limit Their Market. Vedomosti; 2016. Available from: https://www.vedomosti.ru/ business/articles/2016/07/21/649998-aptechnie-seti-ogranichit.

Sergeyeva NM, Reprintseva YV. Marketing strategies of a pharmaceutical organization. Pharm Pharmacol. 2015;5(12):60-3.

Development Strategy of the Pharmaceutical Industry of the Russian Federation for the Period Through to 2020. Available from: http://www.pharma2020.ru. [Last accessed on 2020 Aug 20].

Dolgova IG, Shchepin VO, Proklova TN. Features of the application of SWOT analysis technology to assess the state of the regional system of organization of ophthalmological care for the population of the Tyumen region. Probl Soc Hyg Health Care His Med. 2016;24(6):330-4.

Marketing Concepts. Available from: http://www.ime-link.ru/ concept. [Last accessed on 2020 Aug 20].

Kosyakova NV. Pharmaceutical support for patients with orphan diseases in the subjects of the Southern Federal district: Strengths and weaknesses. Pharmacy. 2018;67(1):36-40.

Patrakhina TN. SWOT-analysis as a tool for planning the strategy of an educational organization. Intern J Sci Sci. 2015;7(2). https://doi.org/10.15862/08pvn215

Ahmadi M, Dileepan P, Wheatley KK. A SWOT analysis of big data. J Educ Bus. 2016;91(5):289-94. https://doi.org/10.1080/0 8832323.2016.1181045

Hollensen S. Global Marketing. 6th ed. United Kingdom: Pearson Education Limited; 2013.

Kerin RA, Hartley SW. Marketing: The Core. 6th ed. New York: McGraw-Hill Education; 2015.

Macbeth DK. Strategic Analysis of Supply Chain Design. United Kingdom: Bookboon; 2015.

Popovich L. Pharmaceutical market perspectives in Russia. Int J Healthc Manage. 2013;6(1):63-5.

Porter ME. Competitive Strategy: Techniques for Analyzing Industries and Competitors. New York: The Free Press; 2017.

Bogomolova YV. SWOT analysis: Theory and practice of application. Econ Anal. 2004;17(32):57-60.

Izosimov SV, Shevchenko AL. The method of SWOT analysis: Its place in research methods, advantages and disadvantages. Economics. 2013;2:29-34.

Hoq MR, Ahsan MA, Tanim-A-Tabassum. A study on SWOT analysis of pharmaceutical industry: The Bangladesh context. Global Dis Econ Bus. 2013;2(2):133-41. https://doi. org/10.18034/gdeb.v2i2.188

Patel MM, Shah PJ, Patel BM. Insights of biosimilars through SWOT analysis. Expert Opin Biol Ther. 2014;14(2):139-44. https://doi.org/10.1517/14712598.2014.849689 PMid:24151903

Paul DR. Propositions on the pharmaceutical marketing AQ8 system. J Pharm Mark Manage. 2002;14(3-4):75-85. https://doi. org/10.1300/j058v14n03_05

Perreault WD Jr., Cannon JP, McCarthy EJ. Essentials of Marketing: A Marketing Strategy Planning Approach. Boston: McGraw-Hill/Irwin; 2013.

Valentin EK. SWOT Analysis from a resource-based view. J Mark Theory Pract. 2001;9(2):54-69.

Krasnokutsky AB, Lagunova AA. Pharmacoeconomics. In: System Analysis of the Global Pharmaceutical Market. Vol. 1. Moscow: Classic Consulting; 1998.

Cundari A. Customer-centric Marketing. Build Relationships, Create Advocates, and Influence Your Customers. United States: John Wiley & Sons Limited; 2015.

Federal State Statistics Service. The Effectiveness of the Russian Economy. Available from: https://www.gks.ru. [Last accessed on 2020 Aug 20].

Harrison DL, Bootman JL. Strategic planning for institutional pharmacy administrators. J Pharm Mark Manage. 1990;5(1):29- 43. https://doi.org/10.3109/j058v05n01_03

Grewal D, Levy M. Marketing. New York: McGraw-Hill/Irwin; 2014.

Kavoura A, Sakas DP. Strategic Innovative Marketing. 4th IC-SIM, Mykonos, Greece 2015. Berlin, Germany: Springer; 2015. https://doi.org/10.1007/978-3-319-33865-1

Saha A, Roberts H. Pharmaceutical industry’s changing market dynamics. Int J Econ Bus. 2020;27(2):1-17.

Smith BD, Awopetu B. Mind-set and market segmentation in the pharmaceutical industry: An assessment of practice in the UK. J Pharm Mark Manage. 2006;17(3-4):101-16. https:// doi.org/10.1300/j058v17n03_07

Stros M, Lee N. Marketing dimensions in the prescription pharmaceutical industry: A systematic literature review. J Strat Mark. 2015;23(4):318-36. https://doi.org/10.1080/09652 54x.2014.931878

Wheeler N, Proctor T. Strategy analysis in the health service. J Mark Manage. 1993;9(3):287-300.

Downloads

Published

2020-09-10

How to Cite

1.
Krylova O, Litvinova T, Babaskina L, Babaskin D, Savinova O. Analysis of the Internal Environment of the Pharmaceutical Distributor Operation in Russia Using SWOT Analysis. Open Access Maced J Med Sci [Internet]. 2020 Sep. 10 [cited 2024 Apr. 25];8(E):382-8. Available from: https://oamjms.eu/index.php/mjms/article/view/3628

Issue

Section

Public Health Legislation

Categories